54gene Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Employees
  • 200

Employees

  • Latest Deal Type
  • Out of Business

54gene General Information

Description

Operator of a genetic testing platform intended to improve the understanding of the human genome. The company's platform provides genetic testing and molecular diagnostics services to patients and physicians and is compliant with international data privacy laws, enabling the healthcare industry to carry out academic research and improve access to life-saving diagnostics.

Contact Information

Website
www.54gene.com
Formerly Known As
Stack Diagnostics
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1100 Fifteenth Street NorthWest
  • Washington, DC 20005
  • United States
Primary Industry
Other Healthcare Technology Systems
Other Industries
Laboratory Services (Healthcare)
Corporate Office
  • 1100 Fifteenth Street NorthWest
  • Washington, DC 20005
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

54gene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 27-Sep-2023 Completed Out of Business
7. Early Stage VC (Series B) 17-May-2022 Completed Generating Revenue
6. Secondary Transaction - Private 01-Jan-2022 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
4. Early Stage VC (Series A) 01-Mar-2020 Completed Generating Revenue
3. Seed Round 03-Jul-2019 Completed Startup
2. Accelerator/Incubator 01-Apr-2019 $150K Completed Startup
1. Accelerator/Incubator 13-Mar-2019 $150K $150K Completed Startup
To view 54gene’s complete valuation and funding history, request access »

54gene Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A-7
Series A-6
Series A-5
Series A-4
Series A-3
Series A-2
Series A-1
Series A 11,833,349 $0.000010 $1.34 $1.34 1x $1.34 30%
Seed 1,240,943 $0.000010 $1 $1 1x $1 3.15%
To view 54gene’s complete cap table history, request access »

54gene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a genetic testing platform intended to improve the understanding of the human genome. The company's platform
Other Healthcare Technology Systems
Washington, DC
200 As of 2026

Irvine, CA
 

Atlanta, GA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

54gene Competitors (21)

One of 54gene’s 21 competitors is Agendia, a Venture Capital-Backed company based in Irvine, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agendia Venture Capital-Backed Irvine, CA
OncoLens Venture Capital-Backed Atlanta, GA
Biodesix Formerly VC-backed Louisville, CO
NeoGenomics Corporation Fort Myers, FL
Futura Genetics Venture Capital-Backed Petah Tikva, Israel
You’re viewing 5 of 21 competitors. Get the full list »

54gene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

54gene FAQs

  • When was 54gene founded?

    54gene was founded in 2019.

  • Where is 54gene headquartered?

    54gene is headquartered in Washington, DC.

  • What is the size of 54gene?

    54gene has 200 total employees.

  • What industry is 54gene in?

    54gene’s primary industry is Other Healthcare Technology Systems.

  • Is 54gene a private or public company?

    54gene is a Private company.

  • What is 54gene’s current revenue?

    The current revenue for 54gene is .

  • How much funding has 54gene raised over time?

    54gene has raised $46.3M.

  • Who are 54gene’s competitors?

    Agendia, OncoLens, Biodesix, NeoGenomics, and Futura Genetics are some of the 21 competitors of 54gene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process